Table 4.
Subjects | n | Study group; age (yr) | Modality | Exercise | Results | Limitations | Ref. |
Men | 22 | Healthy 54 ± 10 | Symptom limited exercise test | Treadmill/bicycle | ↑ EPC + ↑ CAC | [120] | |
Men | 16 | Healthy 25.1 ± 2.7 | Bruce modified | Treadmill | ↑ EPC + ↑ NO level | [121] | |
Men (n = 2); Women (n = 9) | 11 | Healthy 31 ± 16 | 1 h Spinning session | Bicycle 80% HRmax | ↑ OEC | No accurate peak VO2 measurements, no gender differentiation | [122] |
Men | 18 | Healthy (sportive) 32.4 ± 2.3 | Ergometer test | Bicycle 70% IAT 240 min | ↑ EPC | No control | [123] |
Men | 23 | Endurance athletes 62 ± 1.6; Healthy low active 65 ± 1.5 | Exercise test | Treadmill 75% ± 5% VO2max 30 min (5 min ramp-up + 25 min + 3 min cool down) | No change in both groups, no change between groups | [124] | |
Men; Women | 25 | GroupI(n = 11) 23.9 ± 1.4; Group II (n = 14) 36.2 ± 9.3 | Symptom limited cardiopulmonary exercise test | Bicycle ergometer: 40 W warm up; 20 W incremental test | ↑ EPC | Small sample size | [125] |
Men | 25 | Healthy | Running exercise | Protocol 1 30 min 100% IAT; Protocol 2 30 min 80% IAT; Protocol 3 10 min 80% IAT | Protocol 1 ↑ EPC; Protocol 2 ↑ EPC; Protocol 3 no change | [126] | |
Men | 68 | Marathon runners 57 ± 6 | Marathon | Race | No change | [127] | |
Men | 10 | Marathon protocol (n = 9) 43.6 ± 11.6; Field test protocol (n = 8) 43.4 ± 10.9 | Running exercise | Marathon protocol marathon race; Field test protocol 1500 m max speed | Marathon protocol no change; Field test protocol ↑ EPC | [128] | |
Men | 20 | Spartathlon runners (n = 10) 42.8 ± 1.4 Control sedentary (n = 10) 42.2 ± 10.4 | Spartathlon | Exercise group race (246 km); Control group no intervention | Spartathlon runners ↑ EPC; Control no change | [129] |
EPC: Endothelial progenitor cell; CAC: Circulating angiogenic cell; IAT: Individual anaerobic threshold.